02/07/2025
12:21 PM | Collegium Pharmaceutical (Subject)
Invesco Ltd. (Filed by)
| Form SCHEDULE 13G | |
02/05/2025
4:30 PM | Collegium Pharmaceutical (Issuer)
Lurker Nancy (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/05/2025
4:30 PM | Collegium Pharmaceutical (Issuer)
Lurker Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
7:05 AM | Collegium Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/14/2025
3:12 PM | Collegium Pharmaceutical (Issuer)
Kuhlmann Shirley R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
7:05 AM | Collegium Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:50 PM | Collegium Pharmaceutical (Issuer)
Karnani Vikram (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
4:13 PM | Collegium Pharmaceutical (Subject)
PRINCIPAL GLOBAL INVESTORS (Filed by)
| Form SC 13G | |
11/13/2024
3:30 PM | Collegium Pharmaceutical (Subject)
Rubric Capital Management LP (Filed by)
| Form SC 13G/A | |
11/13/2024
1:39 PM | Collegium Pharmaceutical (Subject)
RENAISSANCE TECHNOLOGIES LLC (Filed by)
| Form SCHEDULE 13G | |
09/17/2024
3:32 PM | Collegium Pharmaceutical (Issuer)
Smith Thomas B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for COLL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Collegium Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. |
09/13/2024
9:39 AM | Collegium Pharmaceutical (Subject)
Smith Thomas B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2024
9:06 AM | Collegium Pharmaceutical (Subject)
Smith Thomas B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2024
4:52 PM | Collegium Pharmaceutical (Issuer)
Kuhlmann Shirley R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2024
10:53 AM | Collegium Pharmaceutical (Subject)
Kuhlmann Shirley R. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2024
3:47 PM | Collegium Pharmaceutical (Subject)
Kuhlmann Shirley R. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/04/2024
7:03 AM | Collegium Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
1:41 PM | Collegium Pharmaceutical (Subject)
McFarlane Neil F. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2024
3:34 PM | Collegium Pharmaceutical (Subject)
McFarlane Neil F. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/29/2024
5:02 AM | Collegium Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2024
7:05 AM | Collegium Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2024
3:50 PM | Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/04/2024
3:36 PM | Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Subject)
Collegium Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024
4:22 PM | Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024
12:59 PM | Collegium Pharmaceutical (Subject)
Kuhlmann Shirley R. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/30/2024
12:11 PM | Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024
10:19 AM | Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Subject)
| Form 144/A | |
05/29/2024
9:05 AM | Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024
3:22 PM | Collegium Pharmaceutical (Issuer)
Dreyer Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
11:12 AM | Collegium Pharmaceutical (Subject)
Tupper Colleen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024
9:05 AM | Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/24/2024
3:05 PM | Collegium Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2024
12:01 PM | Collegium Pharmaceutical (Subject)
Dreyer Scott (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
6:20 PM | BOHLIN GAREN G (Reporting)
Collegium Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:21 PM | Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:22 PM | Balice-Gordon Rita J. (Reporting)
Collegium Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:22 PM | Collegium Pharmaceutical (Issuer)
Fallon John A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:22 PM | Collegium Pharmaceutical (Issuer)
Freund John Gordon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:23 PM | Collegium Pharmaceutical (Issuer)
McFarlane Neil F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:23 PM | Collegium Pharmaceutical (Issuer)
Melincoff Gwen A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:23 PM | Collegium Pharmaceutical (Issuer)
SANTINI GINO (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Watch This Robotics Demo Before March 17th (Ad) Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%...
Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." Click here to watch the demo… |
05/14/2024
2:12 PM | BOHLIN GAREN G (Reporting)
Collegium Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/13/2024
7:05 AM | Collegium Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2024
7:02 AM | Collegium Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2024
7:03 AM | Collegium Pharmaceutical (Filer)
| Form DEFA14A | |
05/09/2024
3:07 PM | Collegium Pharmaceutical (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2024
7:05 AM | Collegium Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
7:00 AM | Collegium Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2024
3:26 PM | Collegium Pharmaceutical (Issuer)
Smith Thomas B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:24 PM | Collegium Pharmaceutical (Subject)
Smith Thomas B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024
3:14 PM | Collegium Pharmaceutical (Issuer)
Dreyer Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
3:39 PM | Collegium Pharmaceutical (Subject)
Dreyer Scott (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
